Product Information
FT ANTI-DIARRHEAL 2 MG SOFTGEL is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1363 per EA under NDC 70677106201. Its NADAC has been published 156 times since Oct 11, 2023.
FDA first approved this application on Aug 4, 2005.
Strength
2 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677106201
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021855FDA Approved
8/4/2005
On Market Since
4/21/2023
Pharmacological Classes
Price Statistics
The NADAC for FT ANTI-DIARRHEAL 2 MG SOFTGEL has been published 156 times since Oct 11, 2023, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1363 per EA |
|---|---|
| All-time high | $0.1518 (Dec 13, 2023) |
| All-time low | $0.1324 (Feb 19, 2025) |
| 52-week high | $0.1363 |
| 52-week low | $0.1329 |
| Median price | $0.1352 |
| Average price | $0.1367 |
| Largest weekly change | -9.4% (Mar 20, 2024) |
| Weeks tracked | 156 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LOPERAMIDE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ANTI-DIARRHEAL 2 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for FT ANTI-DIARRHEAL 2 MG SOFTGEL, manufactured by Strategic Sourcing Services LLC, is $0.1363 per EA (NDC 70677106201), effective Sep 30, 2026.
How has the price of FT ANTI-DIARRHEAL 2 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for FT ANTI-DIARRHEAL 2 MG SOFTGEL has declined 9.9%. It has been tracked across 156 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for FT ANTI-DIARRHEAL 2 MG SOFTGEL?
Since Oct 11, 2023, the NADAC for FT ANTI-DIARRHEAL 2 MG SOFTGEL has ranged from a low of $0.1324 (Feb 19, 2025) to a high of $0.1518 (Dec 13, 2023), with a median of $0.1352 per EA.
Are there cheaper alternatives to FT ANTI-DIARRHEAL 2 MG SOFTGEL?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOPERAMIDE 2 MG CAPSULE, is $0.0549 per EA — about 60% below FT ANTI-DIARRHEAL 2 MG SOFTGEL.
Who manufactures FT ANTI-DIARRHEAL 2 MG SOFTGEL?
FT ANTI-DIARRHEAL 2 MG SOFTGEL (NDC 70677106201) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.